CAMBRIDGE, Mass.--(BUSINESS WIRE)--Biogen
Inc. (NASDAQ: BIIB) announced today that it will present at the
Goldman Sachs Alzheimer’s Symposium. The webcast will be live on Monday,
April 11, 2016 at 12:20p.m. ET. To access the live webcast, please visit
Biogen’s Investors section at www.biogen.com/investors.
An archived version of the webcast will be available for 14 days
following the presentation.
About Biogen
Through cutting-edge science andmore...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Biogen
Inc. (NASDAQ:BIIB) today announced it will report first quarter 2016
financial results on Thursday, April 21, 2016, before the financial
markets open.
Following the release of the financials, the Company will host a live
webcast where Biogen management will discuss the financial results, at
8:30 am ET. To access the live webcast, please go to the investor
relations section of Biogen’s website at www.biogen.com/investorsmore...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Biogen
Inc. (NASDAQ: BIIB) announced today that it will present at the
Cowen and Company 36th Annual Health Care Conference. The webcast will
be live on Monday, March 7, 2016 at 3:20p.m. ET. To access the live
webcast, please visit Biogen’s Investors section at www.biogen.com/investors.
An archived version of the webcast will be available for 14 days
following the presentation.
About BiogenThrough cutting-edge science andmore...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Biogen
Inc. (NASDAQ: BIIB) announced today that it will present at the
Leerink Partners 5th Annual Global Healthcare Conference. The
webcast will be live on Thursday, February 11, 2016, at 2:15p.m. ET. To
access the live webcast, please visit Biogen’s Investors section at www.biogen.com.
An archived version of the webcast will be available for 14 days
following the presentation.
About BiogenThrough cutting-edge science andmore...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Biogen Inc. (NASDAQ: BIIB) today reported full year and fourth quarter
2015 results, including full year revenues of $10.8 billion, an 11%
increase versus 2014. Full year 2015 Non-GAAP diluted earnings per share
(EPS) were $17.01, an increase of 23% versus 2014. Non-GAAP net income
attributable to Biogen Inc. for the year was $3.9 billion, an increase
of 20% versus the prior year.
On a reported basis, GAAP diluted EPS for 2015 were $15.more...